- Home
- SVRA vs THFF Comparison
SVRA vs THFF Comparison
Compare SVRA & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRA | THFF |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 930.9M |
| IPO Year | 2009 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SVRA | THFF |
|---|---|---|
| Price | $5.33 | $77.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $7.33 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 1.4M | 80.7K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | N/A | ★ 67.00 |
| EPS | N/A | ★ 3.58 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.88 |
| Revenue Next Year | $430.87 | $4.03 |
| P/E Ratio | ★ N/A | $21.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $51.21 |
| 52 Week High | $7.01 | $84.17 |
Technical Indicators
Market Signals| Indicator | SVRA | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 43.58 |
| Support Level | $5.16 | $74.09 |
| Resistance Level | $5.43 | $78.57 |
| Average True Range (ATR) | 0.20 | 1.72 |
| MACD | -0.00 | -0.30 |
| Stochastic Oscillator | 17.65 | 49.69 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.